Reducing time, sample handling, and staff requirements for complement activation monitoring in clinical trials

减少临床试验中补体激活监测的时间、样品处理和人员需求

基本信息

  • 批准号:
    9141919
  • 负责人:
  • 金额:
    $ 21.82万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-06-10 至 2017-05-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Despite overwhelming evidence that the complement system is involved in kidney and cardiovascular outcomes, stringent technical requirements limit its inclusion in clinical trials and diagnostics. Current protocols require careful sample collectin, immediate freezing, and shipping to only a few specialized labs. As a result, while complement system proteins C3 and C4 are routinely measured in autoimmune disease clinics, proteolytically activated split products known to mediate active inflammatory and autoimmune processes are rarely assessed. Kypha Inc. is developing an integrated point-of-care (POC) platform to make reliable complement data more accessible to clinical trials and diagnostic applications. These efforts are timely due to recent therapeutic development focused on anti-inflammatory strategies including complement inhibition for extracorporeal therapies (such as hemodialysis), autoimmunity, transplant rejection, and other conditions. Milestones in this Phase I proposal will demonstrate the feasibility of using advanced multiplex quantitative lateral flow assays in the point of care as a solution that decreases the resources required to measure complement activation and inflammation in clinical trials, paving the way for their full utility inthe diagnosis and management of acute and chronic renal and vascular inflammatory diseases.
 描述(由申请人提供):尽管有压倒性证据表明补体系统与肾脏和心血管结果有关,但严格的技术要求限制了其在临床试验和诊断中的应用。目前的检测方法需要仔细收集样本,立即冷冻,然后运往几个专门的实验室。因此,虽然补体系统蛋白C3和C4在自身免疫性疾病临床上经常被检测,但已知的介导活跃的炎症和自身免疫过程的蛋白水解性分裂产物很少被评估。Kypha Inc.正在开发一个集成的护理点(POC)平台,以使临床试验和诊断应用程序更容易获得可靠的补体数据。这些努力是及时的,因为最近的治疗发展集中在抗炎策略上,包括体外治疗(如血液透析)、自身免疫、移植排斥反应和其他情况下的补体抑制。这一第一阶段提案中的里程碑将证明在护理点使用先进的多重定量侧向血流分析作为一种解决方案的可行性,以减少在临床试验中测量补体激活和炎症所需的资源,为它们在急慢性肾脏和血管炎症疾病的诊断和管理中的充分应用铺平道路。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Martin J. Schmidt其他文献

Differential impact of GAD67 suppression in distinct GABA-ergic interneuron populations: Implications for mental illness
GAD67 抑制对不同 GABA 能中间神经元群体的不同影响:对精神疾病的影响
  • DOI:
  • 发表时间:
    2014
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Martin J. Schmidt
  • 通讯作者:
    Martin J. Schmidt
Recurrent spinal arachnoid cyst in a cat
  • DOI:
    10.1016/j.jfms.2007.04.006
  • 发表时间:
    2007-12-01
  • 期刊:
  • 影响因子:
  • 作者:
    Martin J. Schmidt;Walter Schachenmayr;Cetina Thiel;Martin Kramer
  • 通讯作者:
    Martin Kramer
High pressure and high strain rate behavior of cementitious materials: Experiments and elastic/viscoplastic modeling
  • DOI:
  • 发表时间:
    2003
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Martin J. Schmidt
  • 通讯作者:
    Martin J. Schmidt
Modeling Interneuron Dysfunction in Schizophrenia
精神分裂症中间神经元功能障碍的建模
  • DOI:
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    2.9
  • 作者:
    Martin J. Schmidt;K. Mirnics
  • 通讯作者:
    K. Mirnics
Incidence of Abnormalities of the Second and Third Cervical Vertebral Junction in Dogs with Atlantoaxial Instability: A Multicentre Study
寰枢椎不稳定的狗第二和第三颈椎交界处异常的发生率:一项多中心研究
  • DOI:
    10.3415/vcot-17-01-0004
  • 发表时间:
    2017
  • 期刊:
  • 影响因子:
    1.3
  • 作者:
    M. Schneider;M. Waschk;Maria Christina Precht;Christina Nathues;Pierre Moissonnier;T. Aikawa;D. Schnötzinger;Martin J. Schmidt;D. Garosi;Franck Forterre
  • 通讯作者:
    Franck Forterre

Martin J. Schmidt的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.82万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 21.82万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.82万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.82万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.82万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.82万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.82万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 21.82万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 21.82万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 21.82万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了